Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001178 · ClinicalTrials.gov registry record
Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- 597
- Enrollment target
NCT00001178: Clinical Trial study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00001178 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 597 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001178 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- 597 participants
- Enrollment target
Study Summary
The Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke proposes to continue its cross-sectional and longitudinal studies of cerebral metabolism in frontal lobe dementias and atypical basal ganglia disorders. These studies include repeated assessments of neuropsychological and brain anatomical and metabolic function in subjects with these important and possibly related brain disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 597 participants |
| Start Date | 1981-01-19 |
| Est. Completion | 2012-12-17 |
Why NCT00001178 stopped before completion
NCT00001178 is an observational study that tracks outcomes without assigning an intervention. The registered 597 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001178 about?
NCT00001178 is a clinical study titled "Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders". The Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke proposes to continue its cross-sectional and longitudinal studies of cerebral metabolism in frontal lobe dementias and atypical basal ganglia disorders. These studies include repeated assessments of neu...
What is the current status of trial NCT00001178?
This trial is currently terminated. The enrollment target is 597 participants. The study started on 1981-01-19. Estimated completion is 2012-12-17.
Who is sponsoring clinical trial NCT00001178?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02138734 · 596 participants · Phase 1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- NCT06797245 · 596 participants · NA
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- NCT07100080 · 596 participants · Phase 2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI